Hypertensive nephropathy classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hypertensive nephropathy}} | {{Hypertensive nephropathy}} | ||
{{CMG}} {{AE}} {{AN}} | {{CMG}} {{AE}} {{AN}} | ||
==Classification== | ==Classification== | ||
Hypertensive nephropathy is divided into two distinct entities: | Hypertensive nephropathy is divided into two distinct entities: | ||
| Line 20: | Line 18: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Needs overview]] | |||
Revision as of 20:55, 28 February 2013
|
Hypertensive nephropathy Microchapters |
|
Differentiating Hypertensive Nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertensive nephropathy classification On the Web |
|
American Roentgen Ray Society Images of Hypertensive nephropathy classification |
|
Risk calculators and risk factors for Hypertensive nephropathy classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Classification
Hypertensive nephropathy is divided into two distinct entities:
- Benign arteriolar nephrosclerosis
- Seen in patients who are hypertensive for a long period of time (> 150/90 mm Hg) but has not progressed to malignant stage.
- Malignant (accelerated) arteriolar nephrosclerosis
- Characterized by sudden elevation of blood pressure (diastolic pressure > 130 mm Hg) along with papilledema, central nervous system manifestations like confusion, cardiac decompensation and acute progressive decline in renal function.